Intco Medical Technology Co., Ltd. (SHE:300677)
China flag China · Delayed Price · Currency is CNY
50.45
+0.37 (0.74%)
Jul 31, 2026, 3:04 PM CST

Intco Medical Technology Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Revenue
10,3199,9269,5236,9196,61416,240
Revenue Growth
5.14%4.23%37.65%4.61%-59.27%17.37%
Gross Profit
2,5382,3742,176942.35837.659,973
Operating Income
1,046909901.75-162.49-70.288,583
Net Income
668.011,0111,465383629.077,430
Earnings Per Share
1.101.572.260.580.9511.00
EPS Growth
-55.32%-30.53%289.65%-38.95%-91.36%-2.73%

Revenue by Segment

Fiscal YearFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Jan '23 Jan '22
Personal Protection
8,8358,6006,1806,00515,807
Rehabilitation Nursing Category
447.87457.67395.79377.81254.73
Other
642.77465.51343.1230.95177.91
Total
9,9269,5236,9196,61416,240

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Investments
12,86413,19118,75113,1818,2708,277
Total Debt
17,64317,50113,2697,1661,580292.05
Net Cash (Debt)
-4,778-4,3105,4826,0156,6897,985
Net Cash Growth
---8.86%-10.08%-16.23%30.68%
Net Cash Per Share
-7.85-6.698.459.1110.1011.82

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Cash Flow
1,7691,8851,079502.411,0658,680
Capital Expenditures
-2,386-2,575-1,789-1,439-1,715-5,444
Free Cash Flow
-617.19-689.72-710.37-936.28-649.763,236
Free Cash Flow Growth
------43.12%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Gross Margin
24.60%23.91%22.85%13.62%12.67%61.41%
Operating Margin
10.14%9.16%9.47%-2.35%-1.06%52.85%
Pretax Margin
8.52%12.39%16.89%6.40%10.65%53.26%
Profit Margin
6.47%10.18%15.39%5.54%9.51%45.75%
FCF Margin
-5.98%-6.95%-7.46%-13.53%-9.82%19.93%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Dividend Per Share
0.1500.1500.1500.0800.0990.625
Dividend Per Share Growth
0%0%87.50%-19.00%-84.20%-66.25%
Dividend Yield
0.30%0.39%0.60%0.35%0.48%1.35%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
PE Ratio
45.9824.9511.0740.0122.054.28
Forward PE
13.3615.8311.931.461.465.01
P/FCF Ratio
-----9.83
PS Ratio
3.172.541.702.222.101.96